AssetMark Inc’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249 | Buy |
+14
| New | +$249 | ﹤0.01% | 2852 |
|
|
2023
Q4 | – | Sell |
-7,166
| Closed | -$116K | – | 1965 |
|
|
2023
Q3 | $116K | Buy |
7,166
+1,938
| +37% | +$31.3K | ﹤0.01% | 957 |
|
|
2023
Q2 | $217K | Buy |
5,228
+586
| +13% | +$24.3K | ﹤0.01% | 834 |
|
|
2023
Q1 | $279K | Sell |
4,642
-1,842
| -28% | -$111K | ﹤0.01% | 788 |
|
|
2022
Q4 | $476K | Buy |
6,484
+802
| +14% | +$58.8K | ﹤0.01% | 710 |
|
|
2022
Q3 | $432K | Buy |
5,682
+1,295
| +30% | +$98.5K | ﹤0.01% | 673 |
|
|
2022
Q2 | $305K | Buy |
4,387
+917
| +26% | +$63.8K | ﹤0.01% | 692 |
|
|
2022
Q1 | $287K | Buy |
3,470
+1,800
| +108% | +$149K | ﹤0.01% | 695 |
|
|
2021
Q4 | $125K | Buy |
1,670
+1,606
| +2,509% | +$120K | ﹤0.01% | 768 |
|
|
2021
Q3 | $7K | Buy |
+64
| New | +$7K | ﹤0.01% | 1094 |
|
|
2020
Q1 | – | Sell |
-14
| Closed | -$1K | – | 1486 |
|
|
2019
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1327 |
|
|
2019
Q3 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 1253 |
|